Skip to main content
Top
Published in: Abdominal Radiology 10/2017

01-10-2017

Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations

Authors: Won Hyeong Im, Ji Soo Song, Eun Hae Park, Hyo Sung Kwak

Published in: Abdominal Radiology | Issue 10/2017

Login to get access

Abstract

Purpose

To determine whether patients undergoing multiple gadoxetate disodium-enhanced magnetic resonance (MR) examinations who experienced transient severe motion (TSM) in the arterial phase were affected by the TSM noted in the first examination.

Materials and methods

214 patients who underwent three or more repeated gadoxetate disodium-enhanced MR imaging were retrospectively analyzed. Three radiologists scored all of the examinations demonstrating a motion artifact using a five-point rating scale. Risk factor analysis and comparison of TSM recurrence rates were performed in the whole study population as well as in a subpopulation of patients with TSM.

Results

The overall incidence of TSM was 5.9% (54/922), which was observed in 40 patients. Thirty-two patients had one episode of TSM, and eight patients had recurrent TSM. Although TSM in the first examination increased the risk of recurrent TSM in the whole population (OR 24.45; P < 0.001), the incidence of recurrent TSM was low (2.4%, 22/922). On subpopulation analysis, TSM in the first examination did not influence recurrent TSM (OR 0.36; P = 0.250).

Conclusion

Patients undergoing multiple gadoxetate disodium-enhanced MR examinations who experienced recurrent TSM were not affected by TSM in the first examination. Therefore, a single episode of TSM should not be considered a risk factor of recurrent TSM.
Literature
1.
go back to reference Bashir MR, Gupta RT, Davenport MS, et al. (2013) Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging 37(2):398–406. doi:10.1002/jmri.23818 CrossRefPubMed Bashir MR, Gupta RT, Davenport MS, et al. (2013) Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging 37(2):398–406. doi:10.​1002/​jmri.​23818 CrossRefPubMed
3.
go back to reference Muhi A, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34(2):326–335. doi:10.1002/jmri.22613 CrossRefPubMed Muhi A, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34(2):326–335. doi:10.​1002/​jmri.​22613 CrossRefPubMed
4.
go back to reference Grazioli L, Bondioni MP, Haradome H, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262(2):520–529. doi:10.1148/radiol.11101742 CrossRefPubMed Grazioli L, Bondioni MP, Haradome H, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262(2):520–529. doi:10.​1148/​radiol.​11101742 CrossRefPubMed
10.
go back to reference Davenport MS, Viglianti BL, Al-Hawary MM, et al. (2013) Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology 266(2):452–461. doi:10.1148/radiol.12120826 CrossRefPubMed Davenport MS, Viglianti BL, Al-Hawary MM, et al. (2013) Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology 266(2):452–461. doi:10.​1148/​radiol.​12120826 CrossRefPubMed
11.
go back to reference Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR (2014) Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology 271(2):426–434. doi:10.1148/radiol.13131988 CrossRefPubMed Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR (2014) Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology 271(2):426–434. doi:10.​1148/​radiol.​13131988 CrossRefPubMed
12.
go back to reference Davenport MS, Caoili EM, Kaza RK, Hussain HK (2014) Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology 272(1):123–131. doi:10.1148/radiol.14132269 CrossRefPubMed Davenport MS, Caoili EM, Kaza RK, Hussain HK (2014) Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology 272(1):123–131. doi:10.​1148/​radiol.​14132269 CrossRefPubMed
13.
go back to reference Bashir MR, Castelli P, Davenport MS, et al. (2015) Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology 274(1):141–148. doi:10.1148/radiol.14140386 CrossRefPubMed Bashir MR, Castelli P, Davenport MS, et al. (2015) Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology 274(1):141–148. doi:10.​1148/​radiol.​14140386 CrossRefPubMed
15.
16.
17.
go back to reference Cruite I, Schroeder M, Merkle EM, Sirlin CB (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195(1):29–41. doi:10.2214/ajr.10.4538 CrossRefPubMed Cruite I, Schroeder M, Merkle EM, Sirlin CB (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195(1):29–41. doi:10.​2214/​ajr.​10.​4538 CrossRefPubMed
18.
go back to reference Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195(1):13–28. doi:10.2214/ajr.10.4392 CrossRefPubMed Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195(1):13–28. doi:10.​2214/​ajr.​10.​4392 CrossRefPubMed
19.
go back to reference Donner A, Eliasziw M (1987) Sample size requirements for reliability studies. Stat Med 6(4):441–448CrossRefPubMed Donner A, Eliasziw M (1987) Sample size requirements for reliability studies. Stat Med 6(4):441–448CrossRefPubMed
21.
go back to reference Gutzeit A, Matoori S, Froehlich JM, et al. (2016) Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command. Eur Radiol 26(8):2714–2722. doi:10.1007/s00330-015-4086-4 CrossRefPubMed Gutzeit A, Matoori S, Froehlich JM, et al. (2016) Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command. Eur Radiol 26(8):2714–2722. doi:10.​1007/​s00330-015-4086-4 CrossRefPubMed
Metadata
Title
Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations
Authors
Won Hyeong Im
Ji Soo Song
Eun Hae Park
Hyo Sung Kwak
Publication date
01-10-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1145-0

Other articles of this Issue 10/2017

Abdominal Radiology 10/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.